Some Indian pharmaceutical companies are facing increased regulatory scrutiny in developed markets and that's perking up the view on the sector., more
Friday, July 31, 2009
Subscribe to:
Post Comments (Atom)
The lastest news and observations about doing business in Asia.
No comments:
Post a Comment